Evidence against association of the FE65 gene (APBB1) intron 13 polymorphism in Alzheimer's patients
- 28 November 2000
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 296 (1) , 17-20
- https://doi.org/10.1016/s0304-3940(00)01607-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer diseaseAnnals of Neurology, 2001
- Significant Evidence for Linkage Disequilibrium over a 5-cM Region among AfrikanersGenomics, 2000
- A Discordant-Sibship Test for Disequilibrium and Linkage: No Need for Parental DataAmerican Journal of Human Genetics, 1998
- Alpha-2 macroglobulin is genetically associated with Alzheimer diseaseNature Genetics, 1998
- Mapping of the human and murine X11-like genes (APBA2 and Apba2 ), the murine Fe65 gene ( Apbb1 ), and the human Fe65-like gene (APBB2): genes encoding phosphotyrosine-binding domain proteins that interact with the Alzheimer's disease amyloid precursor proteinMammalian Genome, 1998
- The Genetics of Alzheimer DiseaseArchives of Neurology, 1998
- ApoE-4 and Age at Onset of Alzheimer's DiseaseNeurology, 1997
- The Phosphotyrosine Interaction Domains of X11 and FE65 Bind to Distinct Sites on the YENPTY Motif of Amyloid Precursor ProteinMolecular and Cellular Biology, 1996
- Association of a novel human FE65-like protein with the cytoplasmic domain of the beta-amyloid precursor protein.Proceedings of the National Academy of Sciences, 1996
- Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's diseaseAnnals of Neurology, 1996